Immunome, Inc. (IMNM)
NASDAQ: IMNM · Real-Time Price · USD
11.59
+1.43 (14.07%)
At close: Sep 26, 2025, 4:00 PM EDT
11.70
+0.11 (0.94%)
After-hours: Sep 26, 2025, 7:59 PM EDT
Immunome Employees
Immunome had 118 employees as of December 31, 2024. The number of employees increased by 63 or 114.55% compared to the previous year.
Employees
118
Change (1Y)
63
Growth (1Y)
114.55%
Revenue / Employee
$106,686
Profits / Employee
-$1,799,881
Market Cap
1.01B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 118 | 63 | 114.55% |
| Dec 31, 2023 | 55 | 18 | 48.65% |
| Dec 31, 2022 | 37 | -2 | -5.13% |
| Dec 31, 2021 | 39 | 16 | 69.57% |
| Dec 31, 2020 | 23 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
IMNM News
- 9 days ago - Infinimmune Announces Research Collaboration with Immunome - Business Wire
- 23 days ago - Immunome Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 24 days ago - Immunome to Present at the H.C. Wainwright 27th Annual Global Investment Conference - Business Wire
- 6 weeks ago - Immunome: SpringWorks Buyout Informs The Potential Upside Here - Seeking Alpha
- 7 weeks ago - Immunome Reports Second Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 4 months ago - Immunome to Present at Upcoming Investor Conferences - Business Wire
- 4 months ago - Immunome Reports First Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 5 months ago - Immunome: Transformed Pipeline Offers Multiple Catalysts - Seeking Alpha